Trial Profile

Randamized phase II trial of S-1+CDDP vs S-1+Docetaxel for advanced and/or recurrent gastric cancer.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 25 Jun 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
Indications Gastric cancer
Focus Therapeutic Use

Most Recent Events

22 Jun 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
23 Jun 2012 Planned end date changed from 1 Jun 2013 to 1 Feb 2014 as reported by University Hospital Medical Information Network - Japan.
20 Jul 2011 Actual initiation date (Jul 2010) as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com